An open toolkit for tracking open science partnership implementation and impact.

Open science impact implementation indicator innovation intellectual property partnership performance policy toolkit

Journal

Gates open research
ISSN: 2572-4754
Titre abrégé: Gates Open Res
Pays: United States
ID NLM: 101717821

Informations de publication

Date de publication:
2019
Historique:
accepted: 08 04 2019
entrez: 19 12 2019
pubmed: 19 12 2019
medline: 19 12 2019
Statut: epublish

Résumé

Serious concerns about the way research is organized collectively are increasingly being raised. They include the escalating costs of research and lower research productivity, low public trust in researchers to report the truth, lack of diversity, poor community engagement, ethical concerns over research practices, and irreproducibility. Open science (OS) collaborations comprise of a set of practices including open access publication, open data sharing and the absence of restrictive intellectual property rights with which institutions, firms, governments and communities are experimenting in order to overcome these concerns. We gathered two groups of international representatives from a large variety of stakeholders to construct a toolkit to guide and facilitate data collection about OS and non-OS collaborations. Ultimately, the toolkit will be used to assess and study the impact of OS collaborations on research and innovation. The toolkit contains the following four elements: 1) an annual report form of quantitative data to be completed by OS partnership administrators; 2) a series of semi-structured interview guides of stakeholders; 3) a survey form of participants in OS collaborations; and 4) a set of other quantitative measures best collected by other organizations, such as research foundations and governmental or intergovernmental agencies. We opened our toolkit to community comment and input. We present the resulting toolkit for use by government and philanthropic grantors, institutions, researchers and community organizations with the aim of measuring the implementation and impact of OS partnership across these organizations. We invite these and other stakeholders to not only measure, but to share the resulting data so that social scientists and policy makers can analyse the data across projects.

Identifiants

pubmed: 31850398
doi: 10.12688/gatesopenres.12958.2
pmc: PMC6904887
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1442

Informations de copyright

Copyright: © 2019 Gold ER et al.

Déclaration de conflit d'intérêts

No competing interests were disclosed.

Références

Nature. 2012 Mar 28;483(7391):531-3
pubmed: 22460880
Elife. 2016 Jul 07;5:
pubmed: 27387362
Nat Hum Behav. 2018 Nov;2(11):793-796
pubmed: 31558810
Nat Chem Biol. 2009 Jul;5(7):436-40
pubmed: 19536100
Elife. 2017 Oct 30;6:
pubmed: 29082866
Proc Natl Acad Sci U S A. 2015 Oct 6;112(40):12240-2
pubmed: 26392553
Science. 2017 Sep 15;357(6356):1101-1102
pubmed: 28912234
Nucleic Acids Res. 2003 Jan 1;31(1):124-7
pubmed: 12519964
Science. 2015 Jun 26;348(6242):1422-5
pubmed: 26113702
Neuron. 2017 Aug 30;95(5):1002-1006
pubmed: 28858611
Science. 2015 Aug 28;349(6251):aac4716
pubmed: 26315443
BMC Med. 2017 Jul 21;15(1):134
pubmed: 28728605
J Health Econ. 2016 May;47:20-33
pubmed: 26928437
Nat Rev Drug Discov. 2009 Dec;8(12):959-68
pubmed: 19949401
Nat Med. 2014 Jun;20(6):564-5
pubmed: 24901552
PLoS Biol. 2016 May 12;14(5):e1002456
pubmed: 27171007
Gates Open Res. 2019 Apr 30;3:1442
pubmed: 31850398
Rand Health Q. 2014 Dec 30;4(3):19
pubmed: 28560088
PLoS Biol. 2016 Dec 7;14(12):e2001259
pubmed: 27932848
Nat Rev Drug Discov. 2011 Jun;10(6):428-38
pubmed: 21629293
MNI Open Res. 2018;2:5
pubmed: 33937623
J Contin Educ Health Prof. 2006 Winter;26(1):13-24
pubmed: 16557505
F1000Res. 2016 Feb 03;5:130
pubmed: 26962436
Perspect Psychol Sci. 2012 Nov;7(6):615-31
pubmed: 26168121
Health Law J. 2008;16:207-35
pubmed: 19536982
MNI Open Res. 2018 Feb 9;2:2
pubmed: 29553146

Auteurs

E Richard Gold (ER)

Centre for Intellectual Property and Policy (CIPP), Faculty of Law, McGill University, Montreal, QC, H3A 1W9, Canada.
Department of Human Genetics, Faculty of Medicine, McGill University, Montreal, QC, H3A 0C7, Canada.

Sarah E Ali-Khan (SE)

Centre for Intellectual Property and Policy (CIPP), Faculty of Law, McGill University, Montreal, QC, H3A 1W9, Canada.
Tanenbaum Open Science Institute (TOSI), Montreal Neurological Institute and Hospital, Montreal, QC, H3A 2B4, Canada.

Liz Allen (L)

F1000, London, W1T 4LB, UK.

Lluis Ballell (L)

Diseases of the Developing World, Global Health R&D, GlaxoSmithKline, Madrid, Spain.

Manoel Barral-Netto (M)

Fundação Oswaldo Cruz - Fiocruz, Rio de Janeiro, RJ, 21040-900, Brazil.

David Carr (D)

Wellcome Trust, London, NW1 2BE, UK.

Damien Chalaud (D)

Montreal Neurological Institute and Hospital, Montreal, QC, H3A 2B4, Canada.

Simon Chaplin (S)

Wellcome Trust, London, NW1 2BE, UK.

Matthew S Clancy (MS)

US Department of Agriculture Economic Research Service, Washington, DC, 20024, USA.

Patricia Clarke (P)

Health Research Board, Dublin, D02 H638, Ireland.

Robert Cook-Deegan (R)

Arizona State University, Washington, DC, 20006, USA.

A P Dinsmore (AP)

Wellcome Trust, London, NW1 2BE, UK.

Megan Doerr (M)

Sage Bionetworks, Seattle, WA, 98121, USA.

Lisa Federer (L)

US National Library of Medicine, Bethesda, MD, 20894, USA.

Steven A Hill (SA)

Research England, UK Research and Innovation, Bristol, BS34 8SR, UK.

Neil Jacobs (N)

Jisc, Bristol, BS2 0JA, UK.

Antoine Jean (A)

Centre for Intellectual Property and Policy (CIPP), Faculty of Law, McGill University, Montreal, QC, H3A 1W9, Canada.

Osmat Azzam Jefferson (OA)

Queensland University of Technology, Brisbane, QLD, 4000, Australia.
The Lens, Canberra, ACT, 2601, Australia.

Chonnettia Jones (C)

Wellcome Trust, London, NW1 2BE, UK.

Linda J Kahl (LJ)

The Lens, Canberra, ACT, 2601, Australia.

Thomas M Kariuki (TM)

African Academy of Sciences, Karen, Nairobi, 00502, Kenya.

Sophie N Kassel (SN)

Centre for Intellectual Property and Policy (CIPP), Faculty of Law, McGill University, Montreal, QC, H3A 1W9, Canada.

Robert Kiley (R)

Wellcome Trust, London, NW1 2BE, UK.

Elizabeth Robboy Kittrie (ER)

US National Library of Medicine, Bethesda, MD, 20894, USA.

Bianca Kramer (B)

Utrecht University Library, Utrecht, CX, 3584, The Netherlands.

Wen Hwa Lee (WH)

Structural Genomics Consortium (SGC), University of Oxford, Oxford, OX3 7DQ, UK.

Emily MacDonald (E)

Centre for Intellectual Property and Policy (CIPP), Faculty of Law, McGill University, Montreal, QC, H3A 1W9, Canada.

Lara M Mangravite (LM)

Sage Bionetworks, Seattle, WA, 98121, USA.

Elizabeth Marincola (E)

African Academy of Sciences, Karen, Nairobi, 00502, Kenya.

Daniel Mietchen (D)

Data Science Institute, University of Virginia, Charlottesville, VA, 22904, USA.

Jennifer C Molloy (JC)

University of Cambridge, Cambridge, CB2 3EA, UK.

Mark Namchuk (M)

Alkermes, Waltham, MA, 02451, USA.

Brian A Nosek (BA)

Department of Psychology, University of Virginia, Charlottesville, VA, 22904-4400, USA.
Center for Open Science, Charlottesville, VA, 22903-5083, USA.

Sébastien Paquet (S)

Element AI, Montreal, QC, H2W 2R2, Canada.

Claude Pirmez (C)

Fundação Oswaldo Cruz - Fiocruz, Rio de Janeiro, RJ, 21040-900, Brazil.

Annabel Seyller (A)

Montreal Neurological Institute and Hospital, Montreal, QC, H3A 2B4, Canada.

Malcolm Skingle (M)

GlaxoSmithKline, Stevenage, Herts, SG1 2NY, UK.

S Nicole Spadotto (SN)

Centre for Intellectual Property and Policy (CIPP), Faculty of Law, McGill University, Montreal, QC, H3A 1W9, Canada.

Sophie Staniszewska (S)

Warwick Research in Nursing, University of Warwick Medical School, Coventry, CV4 7AL, UK.

Mike Thelwall (M)

University of Wolverhampton, Wolverhampton, WV1 1LY, UK.

Classifications MeSH